These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17718717)

  • 1. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
    Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
    Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
    Quinn A; Sercarz EE
    J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
    Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
    J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent.
    Tisch R; Wang B; Serreze DV
    J Immunol; 1999 Aug; 163(3):1178-87. PubMed ID: 10415012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.
    Schloot NC; Daniel D; Norbury-Glaser M; Wegmann DR
    J Autoimmun; 1996 Jun; 9(3):357-63. PubMed ID: 8816971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
    Maron R; Melican NS; Weiner HL
    J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
    Xu XJ; Gearon C; Stevens E; Vergani D; Baum H; Peakman M
    Diabetologia; 1999 May; 42(5):560-5. PubMed ID: 10333048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamic acid decarboxylase-specific CD4+ regulatory T cells.
    Liu CP
    Ann N Y Acad Sci; 2006 Oct; 1079():161-70. PubMed ID: 17130549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
    Gauvrit A; Debailleul M; Vu AT; Sai P; Bach JM
    Clin Exp Immunol; 2004 Aug; 137(2):253-62. PubMed ID: 15270841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
    Sévère S; Gauvrit A; Vu AT; Bach JM
    Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
    Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
    Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.
    Jaeckel E; Klein L; Martin-Orozco N; von Boehmer H
    J Exp Med; 2003 Jun; 197(12):1635-44. PubMed ID: 12796471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
    Bockova J; Elias D; Cohen IR
    J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells to a dominant epitope of GAD65 express a public CDR3 motif.
    Quinn A; McInerney M; Huffman D; McInerney B; Mayo S; Haskins K; Sercarz E
    Int Immunol; 2006 Jun; 18(6):967-79. PubMed ID: 16641112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.